21st Jun 2024 10:29
(Alliance News) - Ondine Biomedical Inc on Friday said that its nasal photodisinfection Steriwave is now available through the NHS Supply Chain.
The Vancouver-based company specialises in photodisinfection-based therapies to prevent and treat a broad spectrum of infections.
Ondine shares rose 13% to 8.50 pence each on Friday morning in London.
The company said the availability makes it easier for NHS hospitals in England and Wales to purchase Steriwave.
"This marks the first time a light-activated antimicrobial has been available through the NHS Supply Chain, a national body which manages the sourcing, delivery and supply of healthcare products to the NHS and healthcare organizations in England and Wales," Ondine said.
Stuart Bond, consultant antimicrobial pharmacist & director of Innovation at Mid Yorkshire Teaching NHS Trust, said: "We are very pleased to be the first NHS Trust to give patients access to this important new technology. SSIs can have a devastating effect on patients and their families, and we are pleased that we have demonstrated the feasibility of using Steriwave in our Orthopaedic Centre of Excellence at Pontefract Hospital. It is a real step forward to making Steriwave more widely available across the Trust."
By Tom Budszus, Alliance News slot editor
Comments and questions to [email protected]
Copyright 2024 Alliance News Ltd. All Rights Reserved.
Related Shares:
Ondine Biomed